XLYNX Materials announced a pioneering breakthrough in the direct photopatterning of colloidal quantum dots (QDs), addressing long-standing challenges in resolution, scalability, and material ...
Algernon Pharmaceuticals Inc., a Canadian clinical stage pharmaceutical development company, announced that its wholly owned subsidiary, Algernon NeuroScience (AGN Neuro), has appointed Validcare as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback